Catherine M. Szyman, CVP, Critical Care at Edwards Lifesciences Corp (EW), sold 5,000 shares at $85.81 ($429K) on 2023-06-13, disclosed to the SEC on 2023-06-13.
Scheduled sale ($429k) by CVP, Critical Care under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| EW | SELL | 2023-09-08 | $380K | — | Filing → |
| EW | SELL | 2023-08-09 | $393K | — | Filing → |
| EW | SELL | 2023-07-10 | $453K | — | Filing → |